Fresh Recalls

FDAClass II · Medical device · Recall Z-2820-2026 · Recalled August 5, 2026

OsteoBallast recall — IsoTis OrthoBiologics, Inc.

Agency report date: August 5, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
OsteoBallast
Company / brand
IsoTis OrthoBiologics
Lot / serial / date codes
REF/UDI-DI/Lots: 56800095/10889981149352/181559, 181550 02-8000-095/10889981149314/181559, 181550
Distribution
US Nationwide distribution in the states of AK, NJ, TN, AR, CA, WA, OH.
Agency product description and boundaries

OsteoBallast, 45 x 17.5 mm (SeaSpine Brand), REF: 56800095. Ballast, 45 x 17.5 mm (IsoTis Brand), REF: 02-8000-095

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc DBM (fill for 45 ¿ 11 mm configuration) instead of approx. 7.5 cc DBM (fill for 45 ¿ 17.5 mm configuration), which may lead to delayed fusion, incomplete fusion, pseudarthrosis, or lack of bone ingrowth.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: OsteoBallast

3. Open the official notice or contact

Official recall ID
Z-2820-2026
Brand
IsoTis OrthoBiologics
Classification
Class II
Units affected
98
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Irvine, CA, United States
Firm address
2 Goodyear Ste A, N/A, 92618-2052

Identifying details (verbatim from the notice)

Product codes / lots
REF/UDI-DI/Lots: 56800095/10889981149352/181559, 181550 02-8000-095/10889981149314/181559, 181550
Distribution
US Nationwide distribution in the states of AK, NJ, TN, AR, CA, WA, OH.
Firm notified the public via
Letter
FDA event ID
99332
Recall initiated
July 2, 2026
FDA classified
July 28, 2026
FDA report date
August 5, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page